Presentation is loading. Please wait.

Presentation is loading. Please wait.

Significance of human β-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections  S. Yanagi, J. Ashitani,

Similar presentations


Presentation on theme: "Significance of human β-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections  S. Yanagi, J. Ashitani,"— Presentation transcript:

1 Significance of human β-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections  S. Yanagi, J. Ashitani, K. Imai, Y. Kyoraku, A. Sano, N. Matsumoto, M. Nakazato  Clinical Microbiology and Infection  Volume 13, Issue 1, Pages (January 2007) DOI: /j x Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

2 Fig. 1 Human β-defensin (hBD) concentrations in serum from healthy volunteers (HV), patients with idiopathic pulmonary fibrosis (IPF) and patients with chronic lower respiratory tract infection (CRI). In the CRI group, open circles indicate patients infected with a mucoid strain of Pseudomonas aeruginosa, and closed circles indicate patients infected with a non-mucoid phenotype of P. aeruginosa. Clinical Microbiology and Infection  , 63-69DOI: ( /j x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

3 Fig. 2 Human β-defensin (hBD) concentrations in epithelial lining fluid from healthy volunteers (HV), patients with idiopathic pulmonary fibrosis (IPF) and patients with chronic lower respiratory tract infection (CRI). In the CRI group, open circles indicate patients infected with a mucoid phenotype of Pseudomonas aeruginosa, and closed circles indicate patients infected with a non-mucoid phenotype of P. aeruginosa. Clinical Microbiology and Infection  , 63-69DOI: ( /j x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions


Download ppt "Significance of human β-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections  S. Yanagi, J. Ashitani,"

Similar presentations


Ads by Google